
The NHS is accelerating its efforts to provide cutting-edge cancer treatments, with a new vaccine trial opening for patients with advanced skin cancer.
This initiative is part of the NHS Cancer Vaccine Launch Pad (CVLP), a program designed to fast-track access to mRNA vaccine clinical trials for various cancer types.